Following his graduation from Rutgers Medical School, Robert Hindes, MD, completed a research fellowship in infectious disease at Harvard Medical School. Robert Hindes, MD, has served as the co-founder and chief medical officer at BeyondWest Pharmaceuticals since July 2012 and has published a number of articles in the New England Journal of Medicine and other publications; most of his writing concerns clinical research evaluating treatments for hepatitis C.
Many myths stem from a fear of hepatitis C. Contrary to popular belief, an individual cannot contract hepatitis C through casual contact such as hugging, kissing, coughing or sneezing. While the virus can spread through sexual contact, the likelihood of transmission is small, but increases if an infected individual has multiple partners.
Individuals contract hepatitis C after coming into contact with infected blood. Statistics show that sharing needles to inject drugs is the most common method of transmission in the United States. In many developing countries where needles are reused for medical procedures, the disease may spread in healthcare settings.
Many myths stem from a fear of hepatitis C. Contrary to popular belief, an individual cannot contract hepatitis C through casual contact such as hugging, kissing, coughing or sneezing. While the virus can spread through sexual contact, the likelihood of transmission is small, but increases if an infected individual has multiple partners.
Individuals contract hepatitis C after coming into contact with infected blood. Statistics show that sharing needles to inject drugs is the most common method of transmission in the United States. In many developing countries where needles are reused for medical procedures, the disease may spread in healthcare settings.